Acceptance and commitment therapy for people with rheumatic disease: Existing evidence and future directions. (15th April 2020)

• Record Type: Journal Article
• Authors: Hegarty, Roisin S.M.; Fletcher, Benjamin D.; Conner, Tamlin S.; Stebbings, Simon; Treharne, Gareth J.
• Is Part Of: Musculoskeletal care. Volume 18:Number 3(2020)
• Page Start: 330
• Page End: 341
• Publication Date: 2020-04-15
• Subjects: acceptance and commitment therapy -- arthritis -- fatigue -- fibromyalgia -- psychological interventions -- rheumatic disease -- systematic review; Musculoskeletal system -- Diseases -- Periodicals; Rheumatology -- Periodicals; 616.7005
• DOI: 10.1002/msc.1464
• Languages: English
• ISSNs: 1478-2189

Abstract

Abstract: Introduction: Despite advances in the management of rheumatic diseases, many patients experience persistent pain and fatigue. Psychological interventions are useful adjunctive treatments, but improvements tend to be small, and progress in this area is needed. The aim of this review was to evaluate the effectiveness of acceptance and commitment therapy (ACT) for the treatment of chronic pain and fatigue in patients with rheumatic disease. Methods: A systematic literature search was conducted in MEDLINE, EMBASE, and PsycINFO for randomised controlled trials (RCTs) of ACT for the treatment of chronic pain and fatigue in patients with rheumatic disease. Ten RCTs that included people with rheumatic disease were identified, rated for risk of bias, and summarised in terms of effects on relevant outcomes (disability, emotional functioning, pain, and quality of life). Results: Treatment with ACT was associated with improvements in physical and emotional functioning, pain, and quality of life in chronic pain patients. The favourable effects of ACT were evident when compared with those of treatment as usual or active control conditions (e.g., pain education and novel medication). There was consistent evidence to show that ACT is beneficial in improving physical and emotional functioning in patients with fibromyalgia but a lack of evidence pertaining to patients with other forms of rheumatic disease. Conclusion: ACT provides benefit for fibromyalgia patients. Further high‐quality research is needed to develop ACT interventions for people with inflammatory rheumatic diseases and to evaluate their effectiveness for managing the pain and fatigue associated with these conditions.